Zelnick Leila R, Morrison Laurie J, Devlin Sean M, Bulger Eileen M, Brasel Karen J, Sheehan Kellie, Minei Joseph P, Kerby Jeffrey D, Tisherman Samuel A, Rizoli Sandro, Karmy-Jones Riyad, van Heest Rardi, Newgard Craig D
1 Department of Biostatistics, University of Washington ROC Clinical Trial Center , Seattle, Washington.
J Neurotrauma. 2014 Jun 1;31(11):1029-38. doi: 10.1089/neu.2013.3122. Epub 2014 May 8.
Traumatic brain injury (TBI) is common and debilitating. Randomized trials of interventions for TBI ideally assess effectiveness by using long-term functional neurological outcomes, but such outcomes are difficult to obtain and costly. If there is little change between functional status at hospital discharge versus 6 months, then shorter-term outcomes may be adequate for use in future clinical trials. Using data from a previously published multi-center, randomized, placebo-controlled TBI clinical trial, we evaluated patterns of missing outcome data, changes in functional status between hospital discharge and 6 months, and three prognostic models to predict long-term functional outcome from covariates available at hospital discharge (functional measures, demographics, and injury characteristics). The Resuscitation Outcomes Consortium Hypertonic Saline trial enrolled 1282 TBI patients, obtaining the primary outcome of 6-month Glasgow Outcome Score Extended (GOSE) for 85% of patients, but missing the primary outcome for the remaining 15%. Patients with missing outcomes had less-severe injuries, higher neurological function at discharge (GOSE), and shorter hospital stays than patients whose GOSE was obtained. Of 1066 (83%) patients whose GOSE was obtained both at hospital discharge and at 6-months, 71% of patients had the same dichotomized functional status (severe disability/death vs. moderate/no disability) after 6 months as at discharge, 28% had an improved functional status, and 1% had worsened. Performance was excellent (C-statistic between 0.88 and 0.91) for all three prognostic models and calibration adequate for two models (p values, 0.22 and 0.85). Our results suggest that multiple imputation of the standard 6-month GOSE may be reasonable in TBI research when the primary outcome cannot be obtained through other means.
创伤性脑损伤(TBI)很常见且会导致功能障碍。理想情况下,TBI干预措施的随机试验通过使用长期功能性神经学结果来评估有效性,但这些结果难以获得且成本高昂。如果出院时与6个月时的功能状态变化不大,那么短期结果可能足以用于未来的临床试验。利用先前发表的一项多中心、随机、安慰剂对照的TBI临床试验的数据,我们评估了缺失结局数据的模式、出院与6个月之间功能状态的变化,以及三种预后模型,以根据出院时可用的协变量(功能指标、人口统计学和损伤特征)预测长期功能结局。复苏结果联盟高渗盐水试验招募了1282名TBI患者,85%的患者获得了6个月格拉斯哥扩展结局量表(GOSE)的主要结局,但其余15%的患者未获得主要结局。与获得GOSE的患者相比,未获得结局的患者损伤较轻,出院时神经功能较高(GOSE),住院时间较短。在出院时和6个月时均获得GOSE的1066名(83%)患者中,71%的患者在6个月后的二分功能状态(严重残疾/死亡与中度/无残疾)与出院时相同,28%的患者功能状态改善,1%的患者功能状态恶化。所有三种预后模型的表现都很出色(C统计量在0.88至0.91之间),两种模型的校准也足够(p值分别为0.22和0.85)。我们的结果表明,当无法通过其他方式获得主要结局时,在TBI研究中对标准6个月GOSE进行多重插补可能是合理的。